Trump’s tariff threats and Kennedy’s anti-vaccine stance make US a hostile environment for pharma companies ...
On appointment, Dr Screaton will become a member of the GSK Board Science Committee and the Corporate Responsibility ...
Sciences Division at the University of Oxford, will replace Dr. Jesse Goodman, who retires following nine years of service. Dr. Screaton brings to GSK extensive expertise in immunology and ...
GSK has teamed up with the University of Oxford on a programme that will try to identify the molecular changes in cells in precancerous stages that could form the basis of vaccines to prevent full ...
PRESS RELEASEOMass Therapeutics appoints Birgitte Volck as Non-Executive DirectorOxford, United Kingdom – 26 February 2025 – ...
In corporate news, Prosus has agreed to acquire Just Eat Takeaway.com for around EUR4.1 billion. Here is what you need to know at the London market open: FTSE 100: called down 3.1 points at 8,656.27 ...
GSK has selected a site currently being constructed on the corner of New Oxford Street and Earnshaw Street – known as the Earnshaw building – for its new HQ, which is currently located to the ...
The economy doesn’t need tweaks – it needs capitalist electric shock therapy. It needs a government brave enough to step back ...
Dr. Screaton, currently Head of the Medical (TASE:BLWV) Sciences Division at the University of Oxford, will replace Dr. Jesse Goodman, who retires following nine years of service. Dr. Screaton brings ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. UK drugmaker GSK is struggling to convince the market that it can deliver on its plans to refill its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results